Report overview
Exportin 1 (Chromosome Region Maintenance 1 Protein Homolog or XPO1) ? Exportin 1 (XPO1) or chromosomal maintenance 1 (CRM1) is a eukaryotic protein. It mediates the nuclear export of cellular proteins bearing a leucine-rich nuclear export signal (NES) and of RNAs. In association with RANBP3, it binds cooperatively to the NES on its target protein and to the GTPase RAN in its active Ran-GTP. Docking of this complex to the nuclear pore complex (NPC) is mediated through binding to nucleoporins. It is involved in U3 snoRNA transport from Cajal bodies to nucleoli. The molecules developed by companies in Pre-Registration, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 1, 1, 3, 1, 3 and 1 respectively.
This report aims to provide a comprehensive presentation of the global market for Exportin 1, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Exportin 1. This report contains market size and forecasts of Exportin 1 in global, including the following market information:
Global Exportin 1 Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Exportin 1 Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Exportin 1 companies in 2022 (%)
The global Exportin 1 market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Chromosome Region Maintenance 1 Protein Homolog Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Exportin 1 include Biogen Inc, CanBas Co Ltd, Jiangsu Carephar Pharmaceutical Co Ltd, Karyopharm Therapeutics Inc, Oita University Institute of Advanced Medicine Inc and Wigen Biomedicine Technology (Shanghai) Co Ltd, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Exportin 1 manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Exportin 1 Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Exportin 1 Market Segment Percentages, by Type, 2022 (%)
Chromosome Region Maintenance 1 Protein Homolog
XPO1
Global Exportin 1 Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Exportin 1 Market Segment Percentages, by Application, 2022 (%)
Oncology
Central Nervous System
Immunology
Genetic Disorders
Infectious Disease
Global Exportin 1 Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Exportin 1 Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Exportin 1 revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Exportin 1 revenues share in global market, 2022 (%)
Key companies Exportin 1 sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Exportin 1 sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Biogen Inc
CanBas Co Ltd
Jiangsu Carephar Pharmaceutical Co Ltd
Karyopharm Therapeutics Inc
Oita University Institute of Advanced Medicine Inc
Wigen Biomedicine Technology (Shanghai) Co Ltd
Outline of Major Chapters:
Chapter 1: Introduces the definition of Exportin 1, market overview.
Chapter 2: Global Exportin 1 market size in revenue and volume.
Chapter 3: Detailed analysis of Exportin 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Exportin 1 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Exportin 1 capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
